Cellectar Biosciences Reports Third Quarter 2017 Financial and Corporate Performance
Nov 09, 2017 21:01 pm UTC| Business
MADISON, Wis., Nov. 09, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company (the “company”), today reported financial results and corporate performance for the...
Kona Grill Reports Third Quarter 2017 Results
Nov 09, 2017 21:01 pm UTC| Business
SCOTTSDALE, Ariz., Nov. 09, 2017 -- Kona Grill, Inc. (NASDAQ:KONA), an American grill and sushi bar, reported financial results for the third quarter ended September 30, 2017. Third Quarter 2017 Key Items vs. Year-Ago...
Endocyte to Present at the Jefferies 2017 London Healthcare Conference
Nov 09, 2017 21:01 pm UTC| Business
WEST LAFAYETTE, Ind., Nov. 09, 2017 -- Endocyte, Inc. (NASDAQ:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s management team...
Avinger Announces Third Quarter 2017 Results
Nov 09, 2017 21:01 pm UTC| Business
REDWOOD CITY, Calif., Nov. 09, 2017 -- Avinger, Inc. (NASDAQ:AVGR) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the third...
AveXis Reports Third Quarter 2017 Financial and Operating Results
Nov 09, 2017 21:00 pm UTC| Business
– First patient has been dosed in pivotal trial of AVXS-101 for SMA Type 1 – – Conference call and webcast November 9 at 4:30 p.m. EST – CHICAGO, Nov. 09, 2017 -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene...
I.D. Systems Reports Third Quarter 2017 Results
Nov 09, 2017 21:00 pm UTC| Business
WOODCLIFF LAKE, N.J., Nov. 09, 2017 -- I.D. Systems, Inc. (NASDAQ:IDSY), a leading provider of enterprise asset management technology and solutions for the Industrial Internet of Things, reported results for the third...
Sales and Earnings Reported by J & J Snack Foods
Nov 09, 2017 21:00 pm UTC| Business
PENNSAUKEN, N.J., Nov. 09, 2017 -- J J Snack Foods Corp. (NASDAQ:JJSF) today announced sales and earnings for its fourth quarter and year ended September 30, 2017. Sales for the fourth quarter (14 weeks) increased...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update